Enovix Corporation Form 8-K Summary
Business Context and Reporting Period
Enovix Corporation filed this Current Report on Form 8-K dated September 28, 2021, with the report signed on September 29, 2021. The filing concerns a change to the company’s fiscal calendar and does not report operating or financial results.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Change Versus Prior Period
- The Audit Committee approved changing the fiscal year-end from December 31 to a fiscal calendar generally consisting of four 13-week quarters.
- The change applies prospectively beginning with the third quarter of the current fiscal year, covering July 1, 2021 through October 3, 2021.
- The current fiscal year will end on January 2, 2022.
- No prior-period operating results will be recast or adjusted.
- The company stated that the change does not constitute a fiscal-year change under Rules 13a-10 or 15d-10; therefore, no transition report is required.
Fiscal Calendar and Outlook
| Fiscal period | Period end |
|---|---|
| Current fiscal year | January 2, 2022 |
| 2023 fiscal year, first quarter | April 3, 2022 |
| 2023 fiscal year, second quarter | July 3, 2022 |
| 2023 fiscal year, third quarter | October 2, 2022 |
| 2023 fiscal year, fourth quarter | January 1, 2023 |
The updated calendar may occasionally include a 14-week fourth quarter. The first such quarter is expected in fiscal year 2025, running from September 29, 2024 through January 5, 2025. The filing provides no management guidance, business outlook, contingencies, or unusual operating items.
Investor Verification Items
- Verify that future quarterly comparisons reflect the revised fiscal calendar and differing quarter lengths.
- Confirm that prior-period results are presented without recast adjustments.
- Review subsequent filings for the effect of the calendar change on reporting dates and year-over-year comparability.
- Verify that the first 14-week fourth quarter occurs in fiscal year 2025 as disclosed.